web analytics

Latest News

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
Government to pay £137 million to Cambridge University, to underwrite EU funding #Brexit https://t.co/FRmhbChaNO
Discuva Ltd @DiscuvaLtd
The dividends of funding basic science, from L. Rafael Reif https://t.co/y1udI3tL1c via @WSJ
Discuva Ltd @DiscuvaLtd
BBC News - Academics 'must not be used as #Brexit pawns' https://t.co/woGlEYc8iT